Is XYL a Buy? What to Consider in 2026

Last updated July 2026

Short answer

The bull case for Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company (XYL) rests on Aging infrastructure and water scarcity: Decades of underinvestment in pipes, pumps and treatment plants across the US and Europe, combined with growing water-stress pressure globally, create a long replacement and upgrade cycle. Revenue (TTM) is ~$9.1B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Organic growth has been flat in recent quarters even as reported revenue grew, so the premium valuation leaves little room for disappointment if utility or industrial demand slows. Whether XYL is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company, operating through four segments: Water Infrastructure (transport and treatment for utilities), Applied Water (pumps and equipment for building and industrial use), Measurement and Control Solutions (smart meters, sensors and the Sensus platform), and Water Solutions and Services (the outsourced treatment and services business built up by the 2023 Evoqua acquisition). Its customers are heavily weighted toward water and wastewater utilities plus industrial users, which gives it exposure to non-discretionary, regulation-driven spending on aging pipes, leak detection, metering and treatment. The investment picture is one of a steady, defensive industrial with a secular tailwind. Water scarcity, aging infrastructure, tightening regulation and the digitization of utilities all support multi-year demand, and the Evoqua deal added recurring services revenue and margin. The trade-off is valuation: Xylem carries a premium earnings multiple that assumes continued margin expansion and mid-single-digit organic growth, so the stock can be sensitive to any organic-growth softness even when reported results beat.

What's the case for buying XYL?

1. Aging infrastructure and water scarcity

Decades of underinvestment in pipes, pumps and treatment plants across the US and Europe, combined with growing water-stress pressure globally, create a long replacement and upgrade cycle. Utilities generally fund this through rate bases and public budgets, which makes the spending relatively resilient across economic cycles. Xylem's breadth across transport, treatment and measurement lets it participate in most stages of that spend.

2. Digital water and smart metering

The Measurement and Control Solutions segment, anchored by the Sensus platform, sells smart water meters, sensors, leak detection and analytics as utilities modernize their networks. This shifts part of the mix toward higher-margin, data-driven and recurring revenue. Adoption is still early in many regions, giving a multi-year runway.

3. Evoqua integration and services mix

The 2023 Evoqua acquisition added scale in outsourced water treatment and services, expanding the recurring-revenue base and supporting margin expansion. Continued synergy capture and cross-selling into industrial and municipal accounts is a central part of management's margin story. Xylem raised its 2026 revenue and margin outlook after a solid first quarter.

What are the risks to XYL?

Organic growth has been flat in recent quarters even as reported revenue grew, so the premium valuation leaves little room for disappointment if utility or industrial demand slows. A large share of revenue depends on municipal and utility budgets that can be delayed by funding cycles, elections or macro pressure. The company carries acquisition-related debt and goodwill from the Evoqua deal, and integration or synergy shortfalls would weigh on margins. Xylem also has meaningful international exposure, adding currency and regional demand risk. Finally, competition in metering and treatment from focused players can pressure pricing in specific product lines.

How is XYL valued? (as of JUNE 2026)

Price

$121.22

Market cap

$28.81B

P/E (TTM)

30.15

Forward P/E

19.87

Price / book

2.57

Beta

1.02

52-week range

$105.29 to $154.27

Snapshot for XYL as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (TTM): ~$9.1B
Q1 2026 revenue: ~$2.1B
2026 revenue guidance (midpoint): ~$9.25B
Q1 2026 adjusted EPS: ~$1.12
Market cap: ~$28B
P/E (TTM): ~34x

Xylem generates roughly $9 billion in annual revenue and beat expectations in Q1 2026, delivering about $2.1 billion of revenue and around $1.12 in adjusted EPS while raising full-year guidance to a midpoint near $9.25 billion. At a market cap around $28 billion and a trailing P/E in the mid-30s, the stock trades at a premium to the broader industrials group, reflecting its pure-play water exposure and margin trajectory. Organic growth was roughly flat in the quarter even as reported revenue rose, so valuation leans on continued margin expansion.

How do you decide if XYL is a buy?

Rather than asking whether XYL is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold XYL indirectly through an index or sector ETF before adding more.

For the full picture, see the XYL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about XYL against your real portfolio and see your actual exposure before deciding.

The bottom line on XYL

The bottom line: Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company's story right now is Aging infrastructure and water scarcity, with revenue (ttm) at ~$9.1B. If you believe that narrative continues, the call is about sizing XYL sensibly and checking overlap with what you own; if you doubt it (the risk: organic growth has been flat in recent quarters even as reported revenue grew, so the premium valuation leaves little room for disappointment if utility or industrial demand slows.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around XYL with Walnut

Use Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is XYL a good stock to buy right now?

The case for Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company right now is Aging infrastructure and water scarcity, with revenue (ttm) at ~$9.1B. If you believe that thesis holds, XYL is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is organic growth has been flat in recent quarters even as reported revenue grew, so the premium valuation leaves little room for disappointment if utility or industrial demand slows. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company do?

Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company, operating through four segments: Water Infrastructure (transport an

What are the main risks of XYL?

What does Xylem do?

Xylem is a water technology company that designs and sells pumps, treatment systems, smart water meters, sensors and analytics, plus outsourced water and wastewater services. Its customers are mainly water utilities, industrial users and commercial buildings across the world.

Is XYL a good investment?

That depends on your goals, time horizon and risk tolerance, and Walnut is not an investment adviser. Xylem is a scaled, pure-play water company with durable demand, but it trades at a premium valuation and has seen flat organic growth recently, so the balance of quality versus price is something to weigh for yourself.

What are Xylem's business segments?

Xylem reports four segments: Water Infrastructure (utility transport and treatment), Applied Water (pumps and equipment for buildings and industry), Measurement and Control Solutions (smart meters and sensors under Sensus), and Water Solutions and Services (treatment and services, expanded by the Evoqua acquisition).

How did Xylem perform in Q1 2026?

Xylem reported about $2.1 billion in Q1 2026 revenue, roughly 3 percent reported growth but flat organically, with adjusted EPS near $1.12 that beat estimates. Management raised full-year 2026 revenue guidance to a midpoint around $9.25 billion.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell XYL; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.